Innate Pharma Stock Quote IPHA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

2.425

Bid

2.35

Ask

2.40

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

177.086M

Previous Close

2.425

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

80,861,000

Dividend Yield

PE Ratio

-23.40

Earnings Per Share (EPS)

-0.09

Revenue

61.64M

Net Profit

-7.57M

Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. It specializes in immuno-oncology, a new therap... Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. It specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by mobilizing the power of the body's immune system to recognize and kill cancer cells. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, avdoralimab, and others. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.innate-pharma.com

Headquarters

Marseille, Bouches-du-rhone, Fra

Founded

1970

Innate Pharma SA is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker IPHA. The last closing price for Innate Pharma was $2.43. Over the last year, Innate Pharma shares have traded in a share price range of $ 0.00 to $ 0.00.

Innate Pharma currently has 80,861,000 shares outstanding. The market capitalization of Innate Pharma is $177.09 million. Innate Pharma has a price to earnings ratio (PE ratio) of -23.40.

L’Assemblée Générale d’Innate Pharma aura lieu le 23 mai 2024

Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce la tenue de son Assemblée Générale annuelle le 23 mai 2024 à 10h30 au siège social...

Innate Pharma présente des données d’efficacité précliniques pour IPH45, son conjugué anticorps-médicament innovant ciblant nectine-4 a l’AACR 2024

IPH45 est un nouveau conjugué anticorps-médicament (ADC) différencié à base d’exatecan et ciblant Nectine-4 Dans des modèles précliniques de tumeurs de la vessie, les données recueillies...

Innate Pharma annonce sa participation à une prochaine Conférence Investisseurs

Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que des membres de son équipe de direction seront présents à la...

Innate Pharma publie son Document D’enregistrement Universel 2023 et son Rapport Annuel 2023 sur « Form 20-F »

Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce que son Document d’enregistrement universel pour l’année 2023 a été déposé auprès...

Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the filing of its 2023 Universal Registration Document (Document d’enregistrement...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
HWHHWH International Inc	$ 1.77 (38.28%)	1.16M
PEGYPineapple Energy Inc	$ 0.063 (37.55%)	21.48M
IBRXImmunityBio Inc	$ 6.53 (32.19%)	1.04M
NUWENewellis Inc	$ 0.4051 (21.29%)	2.25M
HIBBHibbett Inc	$ 86.50 (19.33%)	4.96k
ABEOAbeona Therapeutics Inc	$ 4.04 (-45.11%)	45.5k
GWAVGreenwave Technology Solutions Inc	$ 0.0813 (-35.63%)	526.18k
TTOOT2 Biosystems Inc	$ 2.51 (-20.57%)	27.26k
HUGEFSD Pharma Inc	$ 0.4001 (-18.18%)	1
PHIOPhio Pharmaceuticals Corporation	$ 0.6884 (-17.05%)	9.11k
PEGYPineapple Energy Inc	$ 0.063 (37.55%)	21.48M
NUWENewellis Inc	$ 0.4051 (21.29%)	2.25M
AGBAAGBA Group Holding Ltd	$ 2.94 (17.60%)	1.78M
JAGXJaguar Health Inc	$ 0.1535 (-14.67%)	1.53M
HWHHWH International Inc	$ 1.78 (39.06%)	1.16M